LONDON BROKER RATINGS: RBC raises CVS Group to 'outperform'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
Price | 585.00p on 28-03-2025 | at 12:36:14
---|---|
Change | -2.00p -0.34% |
Buy | 584.00p |
Sell | 583.00p |
Buy / Sell LRE Shares |
Last Trade: | Buy 16.00 at 585.00p |
Day's Volume: | 37,474 |
Last Close: | 587.00p |
Open: | 577.00p |
ISIN: | BMG5361W1047 |
Day's Range | 577.00p - 589.00p |
52wk Range: | 548.00p - 721.00p |
Market Capitalisation: | £1,407m |
VWAP: | 584.7752p |
Shares in Issue: | 241m |
Lancashire Holdings (LRE) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 16 | 585.00p | Automatic Execution |
12:10:11 - 28-Mar-25 |
Buy* | 16 | 585.00p | Automatic Execution |
11:59:25 - 28-Mar-25 |
Unknown* | 2 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 2 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 2 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 2 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 5 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 2 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 2 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Unknown* | 4 | 585.00p | OTC Trade |
11:57:42 - 28-Mar-25 |
Lancashire Holdings (LRE) Regulatory News |
||
Date | Source | Headline |
---|---|---|
24th Mar 2025 3:24 pm | PRN | Director/PDMR Shareholding |
24th Mar 2025 3:20 pm | PRN | Director/PDMR Shareholding |
21st Mar 2025 7:00 am | PRN | Notice of Q1 2025 Trading Statement and Conference Call |
17th Mar 2025 11:54 am | PRN | Director/PDMR Shareholding - RSS Awards |
6th Mar 2025 7:01 am | PRN | Board Committee Changes |
6th Mar 2025 7:00 am | PRN | Final Results |
13th Feb 2025 7:00 am | PRN | Loss estimate relating to California wildfires |
22nd Jan 2025 7:00 am | PRN | Notice of Q4 2024 Earnings Release and Conference Call |
31st Dec 2024 7:30 am | PRN | Director Declaration |
17th Dec 2024 3:06 pm | PRN | Director/PDMR Shareholding |